Literature DB >> 12322782

Inhibition of the mitochondrial respiratory chain by alanine in rat cerebral cortex.

Virginia C Rech1, Luciane R Feksa, Carlos S Dutra-Filho, Angela T S Wyse, Moacir Wajner, Clovis M D Wannmacher.   

Abstract

Alanine is a nutritionally nonessential amino acid synthesized by transamination of pyruvate originated from glucose. Alanine is the principal gluconeogenic amino acid because it can originate pyruvate and glucose through the inverse pathway. Considering that it has been suggested that alanine could be used as a dietary supplement in combination with growth hormone in the treatment of undernourished children affected by some inherited metabolic diseases to induce anabolism, the principal objective of the present work was to measure the activities of the mitochondrial respiratory chain complexes and succinate dehydrogenase in brain cortex of Wistar rats subjected to chronic alanine administration from the 6th to the 21st day of life. We also investigated the in vitro effect of alanine on the activities of mitochondrial respiratory chain complexes and succinate dehydrogenase in the same brain structure of 22-day-old rats. The results showed a reduction of Complex I + III and succinate dehydrogenase activities in brain cortex of rats subjected to alanine administration. We also verified that alanine inhibited the in vitro activity of Complexes I + III by competition with NADH. These results indicate that more investigation would be necessary before considering alanine supplementation as a valid adjuvant therapy to sick children with these disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12322782     DOI: 10.1023/a:1019973719399

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  28 in total

Review 1.  Energetics in the pathogenesis of neurodegenerative diseases.

Authors:  M F Beal
Journal:  Trends Neurosci       Date:  2000-07       Impact factor: 13.837

Review 2.  Neuropathologic aspects of cytochrome C oxidase deficiency.

Authors:  K Tanji; E Bonilla
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

3.  The effect of opposing effectors on activation level of succinate dehydrogenase: equilibrium and kinetic studies.

Authors:  M Gutman
Journal:  Biochemistry       Date:  1976-03-23       Impact factor: 3.162

4.  Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates.

Authors:  L Massieu; P Del Río; T Montiel
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

5.  Localization of endogenous ATPases at the nerve terminal.

Authors:  R G Sorensen; H R Mahler
Journal:  J Bioenerg Biomembr       Date:  1982-12       Impact factor: 2.945

6.  Differential investigation of the capacity of succinate oxidation in human skeletal muscle.

Authors:  J C Fischer; W Ruitenbeek; J A Berden; J M Trijbels; J H Veerkamp; A M Stadhouders; R C Sengers; A J Janssen
Journal:  Clin Chim Acta       Date:  1985-11-29       Impact factor: 3.786

7.  Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: relevance to Parkinson's disease.

Authors:  C Chinopoulos; V Adam-Vizi
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

8.  Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase.

Authors:  S Pitkanen; B H Robinson
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

Review 9.  Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia.

Authors:  A H Schapira
Journal:  Biochim Biophys Acta       Date:  1999-02-09

Review 10.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.